Literature DB >> 28162770

Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras.

Tim Wang1, Haiyan Yu2, Nicholas W Hughes3, Bingxu Liu3, Arek Kendirli4, Klara Klein4, Walter W Chen1, Eric S Lander5, David M Sabatini6.   

Abstract

The genetic dependencies of human cancers widely vary. Here, we catalog this heterogeneity and use it to identify functional gene interactions and genotype-dependent liabilities in cancer. By using genome-wide CRISPR-based screens, we generate a gene essentiality dataset across 14 human acute myeloid leukemia (AML) cell lines. Sets of genes with correlated patterns of essentiality across the lines reveal new gene relationships, the essential substrates of enzymes, and the molecular functions of uncharacterized proteins. Comparisons of differentially essential genes between Ras-dependent and -independent lines uncover synthetic lethal partners of oncogenic Ras. Screens in both human AML and engineered mouse pro-B cells converge on a surprisingly small number of genes in the Ras processing and MAPK pathways and pinpoint PREX1 as an AML-specific activator of MAPK signaling. Our findings suggest general strategies for defining mammalian gene networks and synthetic lethal interactions by exploiting the natural genetic and epigenetic diversity of human cancer cells.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AML; CRISPR; RAS; gene networks; genetic screens; synthetic lethality

Mesh:

Substances:

Year:  2017        PMID: 28162770      PMCID: PMC5445660          DOI: 10.1016/j.cell.2017.01.013

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  62 in total

1.  Functional discovery via a compendium of expression profiles.

Authors:  T R Hughes; M J Marton; A R Jones; C J Roberts; R Stoughton; C D Armour; H A Bennett; E Coffey; H Dai; Y D He; M J Kidd; A M King; M R Meyer; D Slade; P Y Lum; S B Stepaniants; D D Shoemaker; D Gachotte; K Chakraburtty; J Simon; M Bard; S H Friend
Journal:  Cell       Date:  2000-07-07       Impact factor: 41.582

2.  P-Rex1, a PtdIns(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac.

Authors:  Heidi C E Welch; W John Coadwell; Christian D Ellson; G John Ferguson; Simon R Andrews; Hediye Erdjument-Bromage; Paul Tempst; Phillip T Hawkins; Len R Stephens
Journal:  Cell       Date:  2002-03-22       Impact factor: 41.582

Review 3.  Drugging the undruggable RAS: Mission possible?

Authors:  Adrienne D Cox; Stephen W Fesik; Alec C Kimmelman; Ji Luo; Channing J Der
Journal:  Nat Rev Drug Discov       Date:  2014-10-17       Impact factor: 84.694

Review 4.  Lessons from the cancer genome.

Authors:  Levi A Garraway; Eric S Lander
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

5.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

6.  JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.

Authors:  H Quentmeier; R A F MacLeod; M Zaborski; H G Drexler
Journal:  Leukemia       Date:  2006-03       Impact factor: 11.528

7.  Genetic interactions in cancer progression and treatment.

Authors:  Alan Ashworth; Christopher J Lord; Jorge S Reis-Filho
Journal:  Cell       Date:  2011-04-01       Impact factor: 41.582

8.  p21-Activated kinase 1 is required for efficient tumor formation and progression in a Ras-mediated skin cancer model.

Authors:  Hoi Yee Chow; Adrian M Jubb; Jennifer N Koch; Zahara M Jaffer; Dina Stepanova; David A Campbell; Sergio G Duron; Marie O'Farrell; Kathy Q Cai; Andres J P Klein-Szanto; J Silvio Gutkind; Klaus P Hoeflich; Jonathan Chernoff
Journal:  Cancer Res       Date:  2012-09-14       Impact factor: 12.701

9.  Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells.

Authors:  Chad M Toledo; Yu Ding; Pia Hoellerbauer; Ryan J Davis; Ryan Basom; Emily J Girard; Eunjee Lee; Philip Corrin; Traver Hart; Hamid Bolouri; Jerry Davison; Qing Zhang; Justin Hardcastle; Bruce J Aronow; Christopher L Plaisier; Nitin S Baliga; Jason Moffat; Qi Lin; Xiao-Nan Li; Do-Hyun Nam; Jeongwu Lee; Steven M Pollard; Jun Zhu; Jeffery J Delrow; Bruce E Clurman; James M Olson; Patrick J Paddison
Journal:  Cell Rep       Date:  2015-12-07       Impact factor: 9.423

10.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer.

Authors:  Simon A Forbes; David Beare; Prasad Gunasekaran; Kenric Leung; Nidhi Bindal; Harry Boutselakis; Minjie Ding; Sally Bamford; Charlotte Cole; Sari Ward; Chai Yin Kok; Mingming Jia; Tisham De; Jon W Teague; Michael R Stratton; Ultan McDermott; Peter J Campbell
Journal:  Nucleic Acids Res       Date:  2014-10-29       Impact factor: 16.971

View more
  254 in total

Review 1.  Mechanistic and Preclinical Insights from Mouse Models of Hematologic Cancer Characterized by Hyperactive Ras.

Authors:  Anica Wandler; Kevin Shannon
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

Review 2.  The leucine-rich repeat signaling scaffolds Shoc2 and Erbin: cellular mechanism and role in disease.

Authors:  HyeIn Jang; Payton Stevens; Tianyan Gao; Emilia Galperin
Journal:  FEBS J       Date:  2020-07-06       Impact factor: 5.542

Review 3.  RAS-targeted therapies: is the undruggable drugged?

Authors:  Amanda R Moore; Scott C Rosenberg; Frank McCormick; Shiva Malek
Journal:  Nat Rev Drug Discov       Date:  2020-06-11       Impact factor: 84.694

4.  Mapping a diversity of genetic interactions in yeast.

Authors:  Jolanda van Leeuwen; Charles Boone; Brenda J Andrews
Journal:  Curr Opin Syst Biol       Date:  2017-08-12

Review 5.  Posttranslational Modifications of RAS Proteins.

Authors:  Ian Ahearn; Mo Zhou; Mark R Philips
Journal:  Cold Spring Harb Perspect Med       Date:  2018-11-01       Impact factor: 6.915

6.  Temporal Profiling Establishes a Dynamic S-Palmitoylation Cycle.

Authors:  Sang Joon Won; Brent R Martin
Journal:  ACS Chem Biol       Date:  2018-05-23       Impact factor: 5.100

Review 7.  Mechanism and Regulation of Centriole and Cilium Biogenesis.

Authors:  David K Breslow; Andrew J Holland
Journal:  Annu Rev Biochem       Date:  2019-01-11       Impact factor: 23.643

8.  The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3β inhibition.

Authors:  Gabriele Varano; Simon Raffel; Martina Sormani; Federica Zanardi; Silvia Lonardi; Christin Zasada; Laura Perucho; Valentina Petrocelli; Andrea Haake; Albert K Lee; Mattia Bugatti; Ulrike Paul; Eelco Van Anken; Laura Pasqualucci; Raul Rabadan; Reiner Siebert; Stefan Kempa; Maurilio Ponzoni; Fabio Facchetti; Klaus Rajewsky; Stefano Casola
Journal:  Nature       Date:  2017-05-31       Impact factor: 49.962

9.  MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survival.

Authors:  Chih-Shia Lee; Liam C Lee; Tina L Yuan; Sirisha Chakka; Christof Fellmann; Scott W Lowe; Natasha J Caplen; Frank McCormick; Ji Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-01       Impact factor: 11.205

10.  CRISPR-based genetic interaction maps inform therapeutic strategies in cancer.

Authors:  Poornima Ramkumar; Martin Kampmann
Journal:  Transl Cancer Res       Date:  2018-02       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.